Reciprocal functions of Cryptococcus neoformans copper homeostasis machinery during pulmonary infection and meningoencephalitis

Nature Communications

Volumn 5, Issue , 2014, Pages

  Sun, Tian Shu ^a   Ju, Xiao ^a   Gao, Hui Ling ^a   Wang, Tao ^a   Thiele, Dennis J ^b   Li, Jia Yi ^a,c   Wang, Zhan You ^a   Ding, Chen ^a  

^a NORTHEASTERN UNIVERSITY   (China)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; COPPER TRANSPORTER CTR1; COPPER TRANSPORTER CTR4; FUNGAL PROTEIN; UNCLASSIFIED DRUG; CATION TRANSPORT PROTEIN;

BRAIN; COPPER; DETOXIFICATION; GENE EXPRESSION; HOMEOSTASIS; MENINGITIS; PHENOTYPE; RECIPROCITY; VIRULENCE; YEAST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DETOXIFICATION; FUNGAL CELL; FUNGAL VIRULENCE; HOMEOSTASIS; HOST; LUNG INFECTION; MENINGOENCEPHALITIS; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; A J MOUSE; ANIMAL; BIOSYNTHESIS; BRAIN; C57BL MOUSE; CRYPTOCOCCOSIS; FEMALE; GENETICS; ION TRANSPORT; LUNG; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY;

FILOBASIDIELLA NEOFORMANS; FUNGI; MUS;

ANIMALS; BRAIN; CATION TRANSPORT PROTEINS; COPPER; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; HOMEOSTASIS; ION TRANSPORT; LUNG; MENINGOENCEPHALITIS; MICE; MICE, INBRED A; MICE, INBRED C57BL;

EID: 84923295145     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6550     Document Type: Article

References (57)

1. Kim, B. E., Nevitt, T. & Thiele, D. J. Mechanisms for copper acquisition, distribution and regulation. Nat. Chem. Biol. 4, 176-185 (2008).
2. Samanovic, M. I., Ding, C., Thiele, D. J. & Darwin, K. H. Copper in microbial pathogenesis: meddling with the metal. Cell Host Microbe 11, 106-115 (2012).
3. Gutteridge, J. M., Rowley, D. A., Halliwell, B., Cooper, D. F. & Heeley, D. M. Copper and iron complexes catalytic for oxygen radical reactions in sweat from human athletes. Clin. Chim. Acta 145, 267-273 (1985).
4. White, C., Lee, J., Kambe, T., Fritsche, K. & Petris, M. J. A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity. J. Biol. Chem. 284, 33949-33956 (2009).
5. Ding, C. et al. Cryptococcus neoformans copper detoxification machinery is critical for fungal virulence. Cell Host Microbe 13, 265-276 (2013).
6. Festa, R. A., Helsel, M. E., Franz, K. J. & Thiele, D. J. Exploiting Innate immune cell activation of a copper-dependent antimicrobial agent during infection. Chem. Biol. 21, 977-987 (2014).
7. Wolschendorf, F. et al. Copper resistance is essential for virulence of Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 108, 1621-1626 (2011).
8. Upadhyay, S., Torres, G. & Lin, X. Laccases involved in 1, 8-dihydroxynaph-thalene melanin biosynthesis in Aspergillus fumigatus are regulated by developmental factors and copper homeostasis. Eukaryot Cell 12, 1641-1652 (2013).
9. Heitman, J. Cryptococcus: from Human Pathogen to Model Yeast (ASM press, 2011).
10. Kronstad, J. W. et al. Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat. Rev. Microbiol. 9, 193-203 (2011).
11. Hull, C. M. & Heitman, J. Genetics of Cryptococcus neoformans. Annu Rev. Genet. 36, 557-615 (2002).
12. Ding, C. et al. The copper regulon of the human fungal pathogen Cryptococcus neoformans H99. Mol. Microbiol. 81, 1560-1576 (2011).
13. Williamson, P. R. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J. Bacteriol. 176, 656-664 (1994).
14. Cox, G. M. et al. Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages. Infect. Immun. 71, 173-180 (2003).
15. Kronstad, J. et al. Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence. Eukaryot. Cell 11, 109-118 (2012).
16. Johnson, K. R., Zheng, Q. Y., Bykhovskaya, Y., Spirina, O. & Fischel-Ghodsian, N. A nuclear-mitochondrial DNA interaction affecting hearing impairment in mice. Nat. Genet. 27, 191-194 (2001).
17. Ngamskulrungroj, P., Chang, Y., Sionov, E. & Kwon-Chung, K. J. The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model. mBio 3, pii e00103-12 (2012).
18. Waterman, S. R. et al. Role of CTR4 in the virulence of Cryptococcus neoformans. mBio 3, pii e00285-12 (2012).
19. Schmidt, P. J., Ramos-Gomez, M. & Culotta, V. C. A gain of superoxide dismutase (SOD) activity obtained with CCS, the copper metallochaperone for SOD1. J. Biol. Chem. 274, 36952-36956 (1999).
20. Eisses, J. F. & Kaplan, J. H. Molecular characterization of hCTR1, the human copper uptake protein. J. Biol. Chem. 277, 29162-29171 (2002).
21. Nose, Y. et al. Ctr1 is an apical copper transporter in mammalian intestinal epithelial cells in vivo that is controlled at the level of protein stability. J. Biol. Chem. 285, 32385-32392 (2010).
22. Ohrvik, H. et al. Ctr2 regulates biogenesis of a cleaved form of mammalian Ctr1 metal transporter lacking the copper-and cisplatin-binding ecto-domain. Proc. Natl Acad. Sci. USA 110, E4279-E4288 (2013).
23. Ohrvik, H. & Thiele, D. J. The role of Ctr1 and Ctr2 in mammalian copper homeostasis and platinum-based chemotherapy. J. Trace Elem. Med. Biol. (2014).
24. Agarwal, R. P. & Henkin, R. I. Zinc and copper in human cerebrospinal fluid. Biol. Trace Elem. Res. 4, 117-124 (1982).
25. Wagner, D. et al. Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal system. J. Immunol. 174, 1491-1500 (2005).
26. Raja, M. R. et al. A copper hyperaccumulation phenotype correlates with pathogenesis in Cryptococcus neoformans. Metallomics 5, 363-371 (2013).
27. Waterman, S. R. et al. Role of a CUF1/CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans. J. Clin. Invest. 117, 794-802 (2007).
28. Ding, C., Festa, R. A., Sun, T. S. & Wang, Z. Y. Iron and copper as virulence modulators in human fungal pathogens. Mol. Microbiol. 93, 10-23 (2014).
29. Lin, X., Huang, J. C., Mitchell, T. G. & Heitman, J. Virulence attributes and hyphal growth of C. neoformans are quantitative traits and the MATalpha allele enhances filamentation. PLoS Genet. 2, e187 (2006).
30. O'Meara, T. R. et al. The Cryptococcus neoformans Rim101 transcription factor directly regulates genes required for adaptation to the host. Mol. Cell. Biol. 34, 673-684 (2014).
31. De Feo, C. J., Aller, S. G., Siluvai, G. S., Blackburn, N. J. & Unger, V. M. Three-dimensional structure of the human copper transporter hCTR1. Proc. Natl Acad. Sci. USA 106, 4237-4242 (2009).
32. Chun, C. D. & Madhani, H. D. Ctr2 links copper homeostasis to polysaccharide capsule formation and phagocytosis inhibition in the human fungal pathogen Cryptococcus neoformans. PLoS ONE 5, e12503 (2010).
33. Beaudoin, J., Laliberte, J. & Labbe, S. Functional dissection of Ctr4 and Ctr5 amino-terminal regions reveals motifs with redundant roles in copper transport. Microbiology 152, 209-222 (2006).
34. Dancis, A. et al. Molecular characterization of a copper transport protein in S. cerevisiae: an unexpected role for copper in iron transport. Cell 76, 393-402 (1994).
35. Marvin, M. E., Williams, P. H. & Cashmore, A. M. The Candida albicans CTR1 gene encodes a functional copper transporter. Microbiology 149, 1461-1474 (2003).
36. Nose, Y., Kim, B. E. & Thiele, D. J. Ctr1 drives intestinal copper absorption and is essential for growth, iron metabolism, and neonatal cardiac function. Cell Metab. 4, 235-244 (2006).
37. Zhou, H., Cadigan, K. M. & Thiele, D. J. A copper-regulated transporter required for copper acquisition, pigmentation, and specific stages of development in Drosophila melanogaster. J. Biol. Chem. 278, 48210-48218 (2003).
38. Ding, C. & Butler, G. Development of a gene knockout system in Candida parapsilosis reveals a conserved role for BCR1 in biofilm formation. Eukaryot. Cell 6, 1310-1319 (2007).
39. Kwon-Chung, K. J., Varma, A., Edman, J. C. & Bennett, J. E. Selection of ura5 and ura3 mutants from the two varieties of Cryptococcus neoformans on 5-fluoroorotic acid medium. J. Med. Vet. Mycol. 30, 61-69 (1992).
40. Staab, J. F. & Sundstrom, P. URA3 as a selectable marker for disruption and virulence assessment of Candida albicans genes. Trends Microbiol. 11, 69-73 (2003).
41. Lay, J. et al. Altered expression of selectable marker URA3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies. Infect Immun. 66, 5301-5306 (1998).
42. Varma, A., Edman, J. C. & Kwon-Chung, K. J. Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans. Infect Immun. 60, 1101-1108 (1992).
43. Dancis, A., Haile, D., Yuan, D. S. & Klausner, R. D. The Saccharomyces cerevisiae copper transport protein (Ctr1p). Biochemical characterization, regulation by copper, and physiologic role in copper uptake. J. Biol. Chem. 269, 25660-25667 (1994).
44. Tseng, H. K. et al. Identification of genes from the fungal pathogen Cryptococcus neoformans related to transmigration into the central nervous system. PLoS ONE 7, e45083 (2012).
45. He, X. et al. Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination. Am. J. Pathol. 181, 1356-1366 (2012).
46. Ransohoff, R. M. & Brown, M. A. Innate immunity in the central nervous system. J. Clin. Invest. 122, 1164-1171 (2012).
47. Zhou, Q., Gault, R. A., Kozel, T. R. & Murphy, W. J. Protection from direct cerebral cryptococcus infection by interferon-gamma-dependent activation of microglial cells. J. Immunol. 178, 5753-5761 (2007).
48. Brambilla, R. et al. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 202, 145-156 (2005).
49. Ayton, S., Lei, P. & Bush, A. I. Metallostasis in Alzheimer's disease. Free Radic. Biol. Med. 62, 76-89 (2013).
50. Hua, J., Meyer, J. D. & Lodge, J. K. Development of positive selectable markers for the fungal pathogen Cryptococcus neoformans. Clin. Diagn. Lab. Immunol. 7, 125-128 (2000).
51. Toffaletti, D. L., Rude, T. H., Johnston, S. A., Durack, D. T. & Perfect, J. R. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol. 175, 1405-1411 (1993).
52. O'Meara, T. R. et al. Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule. PLoS Pathog. 6, e1000776 (2010).
53. Casadevall, A. et al. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob. Agents Chemother. 42, 1437-1446 (1998).
54. Hoebeeck, J., Speleman, F. & Vandesompele, J. Real-time quantitative PCR as an alternative to Southern blot or fluorescence in situ hybridization for detection of gene copy number changes. Methods Mol. Biol. 353, 205-226 (2007).
55. Wang, Y. et al. Two major inositol transporters and their role in cryptococcal virulence. Eukaryot. Cell 10, 618-628 (2011).
56. Sabiiti, W. et al. Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis. J. Clin. Invest. 124, 2000-2008 (2014).
57. Ding, C. et al. Conserved and divergent roles of Bcr1 and CFEM proteins in Candida parapsilosis and Candida albicans. PLoS ONE 6, e28151 (2011).